| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | ADAMTS2 FNTB PEG10 SUV39H1 ERVK-8 GATA3 GATA4 LANCL1 ERVK-19 NR1H3 NR1H2 NR5A1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 AR SHANK3 ZCCHC13 POLR3A ADH4 | 4.50e-11 | 891 | 90 | 22 | GO:0008270 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.75e-10 | 37 | 90 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | transition metal ion binding | FN1 ADAMTS2 FNTB PEG10 SUV39H1 ERVK-8 GATA3 GATA4 LANCL1 ERVK-19 NR1H3 NR1H2 NR5A1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 MUC2 AR SHANK3 ZCCHC13 POLR3A ADH4 | 3.11e-10 | 1189 | 90 | 24 | GO:0046914 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.36e-10 | 38 | 90 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | structural molecule activity | SLIT2 FRAS1 FBN1 MARVELD1 FN1 CSRP2 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 TUBGCP4 ERVK-24 MUC2 SHANK3 | 2.09e-06 | 891 | 90 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.42e-05 | 11 | 90 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | 3-mercaptopyruvate sulfurtransferase activity | 2.01e-05 | 2 | 90 | 2 | GO:0016784 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.27e-05 | 37 | 90 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | endopeptidase activity | NLN THOP1 ADAMTS2 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 | 2.38e-05 | 430 | 90 | 10 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.11e-05 | 14 | 90 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 5.45e-05 | 46 | 90 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.11e-04 | 21 | 90 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | integrin binding | 1.41e-04 | 175 | 90 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 1.55e-04 | 60 | 90 | 4 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 1.65e-04 | 61 | 90 | 4 | GO:0098531 | |
| GeneOntologyMolecularFunction | thiosulfate sulfurtransferase activity | 1.99e-04 | 5 | 90 | 2 | GO:0004792 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 4.48e-04 | 79 | 90 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 6.66e-04 | 38 | 90 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | peptidase activity | NLN THOP1 ADAMTS2 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 | 7.18e-04 | 654 | 90 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | sulfurtransferase activity | 1.29e-03 | 12 | 90 | 2 | GO:0016783 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.58e-03 | 51 | 90 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.61e-03 | 188 | 90 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 1.86e-03 | 54 | 90 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.96e-03 | 55 | 90 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.31e-03 | 16 | 90 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.78e-03 | 417 | 90 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 3.35e-03 | 136 | 90 | 4 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 3.35e-03 | 136 | 90 | 4 | GO:0004519 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.41e-03 | 323 | 90 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 3.62e-03 | 20 | 90 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.71e-03 | 140 | 90 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | peptidase activator activity | 3.90e-03 | 70 | 90 | 3 | GO:0016504 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.99e-03 | 21 | 90 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 4.06e-03 | 71 | 90 | 3 | GO:0042054 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 4.56e-03 | 74 | 90 | 3 | GO:0016782 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 4.78e-03 | 23 | 90 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 4.97e-03 | 152 | 90 | 4 | GO:0016779 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.81e-06 | 85 | 89 | 6 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.81e-06 | 85 | 89 | 6 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.37e-06 | 89 | 89 | 6 | GO:0006949 | |
| GeneOntologyBiologicalProcess | cyanate catabolic process | 1.84e-05 | 2 | 89 | 2 | GO:0009440 | |
| GeneOntologyBiologicalProcess | cyanate metabolic process | 1.84e-05 | 2 | 89 | 2 | GO:0009439 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.15e-05 | 13 | 89 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 2.37e-05 | 39 | 89 | 4 | GO:0003180 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 2.51e-05 | 134 | 89 | 6 | GO:0003279 | |
| GeneOntologyBiologicalProcess | developmental growth | SLIT2 SFRP2 FN1 CD9 DHCR7 SUV39H1 GATA3 GATA4 LRP1 LRP6 PRMT2 CD81 AR NOTCH1 | 3.39e-05 | 911 | 89 | 14 | GO:0048589 |
| GeneOntologyBiologicalProcess | cardiac chamber development | 3.71e-05 | 212 | 89 | 7 | GO:0003205 | |
| GeneOntologyBiologicalProcess | aortic valve development | 4.60e-05 | 46 | 89 | 4 | GO:0003176 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 4.64e-05 | 91 | 89 | 5 | GO:0003281 | |
| GeneOntologyBiologicalProcess | regulation of secretion of lysosomal enzymes | 5.51e-05 | 3 | 89 | 2 | GO:0090182 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 6.41e-05 | 50 | 89 | 4 | GO:1905314 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 7.02e-05 | 161 | 89 | 6 | GO:0003206 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 7.02e-05 | 161 | 89 | 6 | GO:0003231 | |
| GeneOntologyBiologicalProcess | cardiac right ventricle morphogenesis | 9.76e-05 | 21 | 89 | 3 | GO:0003215 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway, planar cell polarity pathway | 1.10e-04 | 4 | 89 | 2 | GO:0141113 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway involved in somitogenesis | 1.10e-04 | 4 | 89 | 2 | GO:0090244 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 1.40e-04 | 61 | 89 | 4 | GO:1902895 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 1.59e-04 | 63 | 89 | 4 | GO:0003179 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-8 ERVK-19 CD81 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 NOTCH1 | 1.77e-04 | 464 | 89 | 9 | GO:0016032 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | SLIT2 SFRP2 FN1 CD9 CSRP2 ERVK-8 GATA3 GATA4 LRP6 ERVK-19 CD81 ERVK-21 ERVK-9 AR SHANK3 NOTCH1 CRB1 | 1.78e-04 | 1483 | 89 | 17 | GO:0048646 |
| GeneOntologyBiologicalProcess | mitral valve formation | 1.83e-04 | 5 | 89 | 2 | GO:0003192 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 2.11e-04 | 27 | 89 | 3 | GO:0010875 | |
| GeneOntologyBiologicalProcess | integrin activation | 2.62e-04 | 29 | 89 | 3 | GO:0033622 | |
| GeneOntologyBiologicalProcess | negative regulation of pinocytosis | 2.73e-04 | 6 | 89 | 2 | GO:0048550 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA metabolic process | 2.81e-04 | 73 | 89 | 4 | GO:2000630 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | FBN1 SCGB2A2 GATA4 SCNN1D PRMT2 NR1H3 NR1H2 NR5A1 SLC39A14 AR NOTCH1 | 2.90e-04 | 727 | 89 | 11 | GO:0032870 |
| GeneOntologyBiologicalProcess | heart valve development | 3.62e-04 | 78 | 89 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 3.81e-04 | 7 | 89 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | myoblast fusion involved in skeletal muscle regeneration | 3.81e-04 | 7 | 89 | 2 | GO:0014905 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 4.08e-04 | 412 | 89 | 8 | GO:0090287 | |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 4.59e-04 | 83 | 89 | 4 | GO:1902893 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 4.71e-04 | 421 | 89 | 8 | GO:0060562 | |
| GeneOntologyBiologicalProcess | mammary gland epithelium development | 4.80e-04 | 84 | 89 | 4 | GO:0061180 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 4.80e-04 | 84 | 89 | 4 | GO:0061614 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 4.83e-04 | 150 | 89 | 5 | GO:0090288 | |
| GeneOntologyBiologicalProcess | negative regulation of response to type II interferon | 5.07e-04 | 8 | 89 | 2 | GO:0060331 | |
| GeneOntologyBiologicalProcess | negative regulation of type II interferon-mediated signaling pathway | 5.07e-04 | 8 | 89 | 2 | GO:0060336 | |
| GeneOntologyBiologicalProcess | positive regulation of lipoprotein lipase activity | 5.07e-04 | 8 | 89 | 2 | GO:0051006 | |
| GeneOntologyBiologicalProcess | regulation of type 2 immune response | 5.43e-04 | 37 | 89 | 3 | GO:0002828 | |
| GeneOntologyBiologicalProcess | cardiac ventricle morphogenesis | 5.73e-04 | 88 | 89 | 4 | GO:0003208 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 5.98e-04 | 89 | 89 | 4 | GO:0060411 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 6.50e-04 | 9 | 89 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | atrioventricular valve formation | 6.50e-04 | 9 | 89 | 2 | GO:0003190 | |
| GeneOntologyBiologicalProcess | negative regulation of non-canonical Wnt signaling pathway | 6.50e-04 | 9 | 89 | 2 | GO:2000051 | |
| GeneOntologyBiologicalProcess | pericardium morphogenesis | 6.50e-04 | 9 | 89 | 2 | GO:0003344 | |
| GeneOntologyBiologicalProcess | regulation of pancreatic juice secretion | 6.50e-04 | 9 | 89 | 2 | GO:0090186 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway involved in heart development | 6.50e-04 | 9 | 89 | 2 | GO:0061311 | |
| GeneOntologyBiologicalProcess | positive regulation of triglyceride lipase activity | 6.50e-04 | 9 | 89 | 2 | GO:0061365 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 6.60e-04 | 244 | 89 | 6 | GO:0009755 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 6.84e-04 | 40 | 89 | 3 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 6.84e-04 | 40 | 89 | 3 | GO:0032376 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | FBN1 PNPLA4 DHCR7 GATA3 LRP1 NR5A1 UGT2B28 SLC39A14 PFKM ADH4 | 7.24e-04 | 684 | 89 | 10 | GO:0010817 |
| GeneOntologyBiologicalProcess | myotube differentiation | 7.25e-04 | 164 | 89 | 5 | GO:0014902 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 7.35e-04 | 94 | 89 | 4 | GO:0003151 | |
| GeneOntologyBiologicalProcess | regulation of lipase activity | 7.35e-04 | 41 | 89 | 3 | GO:0060191 | |
| GeneOntologyBiologicalProcess | growth | SLIT2 SFRP2 FN1 CD9 DHCR7 SUV39H1 GATA3 GATA4 LRP1 LRP6 PRMT2 CD81 AR NOTCH1 | 7.95e-04 | 1235 | 89 | 14 | GO:0040007 |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 2 cell cytokine production | 8.10e-04 | 10 | 89 | 2 | GO:2000553 | |
| GeneOntologyBiologicalProcess | secretion of lysosomal enzymes | 8.10e-04 | 10 | 89 | 2 | GO:0033299 | |
| GeneOntologyBiologicalProcess | sex differentiation | 8.26e-04 | 352 | 89 | 7 | GO:0007548 | |
| GeneOntologyBiologicalProcess | male gonad development | 8.74e-04 | 171 | 89 | 5 | GO:0008584 | |
| GeneOntologyBiologicalProcess | tissue regeneration | 8.92e-04 | 99 | 89 | 4 | GO:0042246 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 8.98e-04 | 172 | 89 | 5 | GO:0046546 | |
| GeneOntologyBiologicalProcess | mammary gland duct morphogenesis | 9.67e-04 | 45 | 89 | 3 | GO:0060603 | |
| GeneOntologyBiologicalProcess | sulfur amino acid catabolic process | 9.87e-04 | 11 | 89 | 2 | GO:0000098 | |
| GeneOntologyBiologicalProcess | cellular response to X-ray | 9.87e-04 | 11 | 89 | 2 | GO:0071481 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation involved in prostate gland development | 9.87e-04 | 11 | 89 | 2 | GO:0060768 | |
| GeneOntologyBiologicalProcess | myotube differentiation involved in skeletal muscle regeneration | 9.87e-04 | 11 | 89 | 2 | GO:0014908 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 1.03e-03 | 103 | 89 | 4 | GO:2000628 | |
| GeneOntologyBiologicalProcess | negative regulation of cytokine-mediated signaling pathway | 1.15e-03 | 106 | 89 | 4 | GO:0001960 | |
| GeneOntologyBiologicalProcess | negative regulation of cold-induced thermogenesis | 1.17e-03 | 48 | 89 | 3 | GO:0120163 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.17e-03 | 48 | 89 | 3 | GO:0000731 | |
| GeneOntologyBiologicalProcess | negative regulation of cholesterol storage | 1.18e-03 | 12 | 89 | 2 | GO:0010887 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in prostate gland development | 1.18e-03 | 12 | 89 | 2 | GO:0060767 | |
| GeneOntologyBiologicalProcess | foregut morphogenesis | 1.18e-03 | 12 | 89 | 2 | GO:0007440 | |
| GeneOntologyBiologicalProcess | tube formation | 1.30e-03 | 187 | 89 | 5 | GO:0035148 | |
| GeneOntologyBiologicalProcess | regulation of animal organ morphogenesis | 1.32e-03 | 110 | 89 | 4 | GO:2000027 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 1.35e-03 | 383 | 89 | 7 | GO:0048608 | |
| GeneOntologyBiologicalProcess | negative regulation of response to cytokine stimulus | 1.36e-03 | 111 | 89 | 4 | GO:0060761 | |
| GeneOntologyBiologicalProcess | Leydig cell differentiation | 1.39e-03 | 13 | 89 | 2 | GO:0033327 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 1.39e-03 | 51 | 89 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 1.40e-03 | 190 | 89 | 5 | GO:0016331 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.40e-03 | 619 | 89 | 9 | GO:0002009 | |
| GeneOntologyBiologicalProcess | reproductive system development | 1.45e-03 | 388 | 89 | 7 | GO:0061458 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 1.50e-03 | 286 | 89 | 6 | GO:0042445 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 1.51e-03 | 391 | 89 | 7 | GO:0051146 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 1.62e-03 | 14 | 89 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | phosphatidylcholine acyl-chain remodeling | 1.62e-03 | 14 | 89 | 2 | GO:0036151 | |
| GeneOntologyBiologicalProcess | regulation of pinocytosis | 1.62e-03 | 14 | 89 | 2 | GO:0048548 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 2 cell cytokine production | 1.62e-03 | 14 | 89 | 2 | GO:2000551 | |
| GeneOntologyBiologicalProcess | pancreatic juice secretion | 1.62e-03 | 14 | 89 | 2 | GO:0030157 | |
| GeneOntologyBiologicalProcess | gonad development | 1.66e-03 | 292 | 89 | 6 | GO:0008406 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 1.68e-03 | 198 | 89 | 5 | GO:0048754 | |
| GeneOntologyBiologicalProcess | response to hormone | FBN1 SCGB2A2 GATA4 SCNN1D LRP6 PRMT2 NR1H3 NR1H2 NR5A1 SLC39A14 AR NOTCH1 | 1.70e-03 | 1042 | 89 | 12 | GO:0009725 |
| GeneOntologyBiologicalProcess | male sex differentiation | 1.71e-03 | 199 | 89 | 5 | GO:0046661 | |
| GeneOntologyBiologicalProcess | regulation of myotube differentiation | 1.73e-03 | 55 | 89 | 3 | GO:0010830 | |
| GeneOntologyBiologicalProcess | type 2 immune response | 1.73e-03 | 55 | 89 | 3 | GO:0042092 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 1.73e-03 | 55 | 89 | 3 | GO:0060071 | |
| HumanPheno | Absent hair | 1.38e-05 | 61 | 27 | 5 | HP:0002298 | |
| HumanPheno | Clitoral hypertrophy | 2.71e-05 | 70 | 27 | 5 | HP:0008665 | |
| HumanPheno | Abnormal size of the clitoris | 2.71e-05 | 70 | 27 | 5 | HP:0040252 | |
| HumanPheno | Increased size of the clitoris | 2.71e-05 | 70 | 27 | 5 | HP:0040253 | |
| HumanPheno | Absent facial hair | 4.09e-05 | 38 | 27 | 4 | HP:0002550 | |
| HumanPheno | Abnormal vagina morphology | 4.30e-05 | 128 | 27 | 6 | HP:0000142 | |
| HumanPheno | Increased total bilirubin | 4.65e-05 | 14 | 27 | 3 | HP:0003573 | |
| HumanPheno | Fused labia majora | 8.09e-05 | 3 | 27 | 2 | HP:0025486 | |
| HumanPheno | Female external genitalia in individual with 46,XY karyotype | 8.60e-05 | 17 | 27 | 3 | HP:0008730 | |
| HumanPheno | Urogenital sinus anomaly | 1.03e-04 | 18 | 27 | 3 | HP:0100779 | |
| HumanPheno | Abnormal clitoris morphology | 1.51e-04 | 100 | 27 | 5 | HP:0000056 | |
| Domain | EGF-like_dom | SELP SLIT2 FRAS1 FBN1 FCGBP CELSR3 PRF1 LRP1 LRP6 NOTCH1 CRB1 | 1.31e-08 | 249 | 83 | 11 | IPR000742 |
| Domain | EGF | 8.95e-08 | 235 | 83 | 10 | SM00181 | |
| Domain | EGF_1 | 1.91e-07 | 255 | 83 | 10 | PS00022 | |
| Domain | - | 1.94e-07 | 57 | 83 | 6 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 2.16e-07 | 58 | 83 | 6 | IPR013088 | |
| Domain | EGF-like_CS | 2.37e-07 | 261 | 83 | 10 | IPR013032 | |
| Domain | EGF_3 | 9.93e-07 | 235 | 83 | 9 | PS50026 | |
| Domain | VWC_out | 1.34e-06 | 19 | 83 | 4 | SM00215 | |
| Domain | EGF | 1.46e-06 | 126 | 83 | 7 | PF00008 | |
| Domain | EGF_2 | 2.68e-06 | 265 | 83 | 9 | PS01186 | |
| Domain | ASX_HYDROXYL | 5.48e-06 | 100 | 83 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.68e-06 | 106 | 83 | 6 | IPR000152 | |
| Domain | EGF_CA | 1.72e-05 | 122 | 83 | 6 | SM00179 | |
| Domain | TIL | 1.81e-05 | 12 | 83 | 3 | PF01826 | |
| Domain | C8 | 1.81e-05 | 12 | 83 | 3 | PF08742 | |
| Domain | EGF-like_Ca-bd_dom | 1.89e-05 | 124 | 83 | 6 | IPR001881 | |
| Domain | RHODANESE_2 | 1.95e-05 | 2 | 83 | 2 | PS00683 | |
| Domain | RHODANESE_1 | 1.95e-05 | 2 | 83 | 2 | PS00380 | |
| Domain | Liver_X_rcpt | 1.95e-05 | 2 | 83 | 2 | IPR023257 | |
| Domain | Unchr_dom_Cys-rich | 2.34e-05 | 13 | 83 | 3 | IPR014853 | |
| Domain | C8 | 2.34e-05 | 13 | 83 | 3 | SM00832 | |
| Domain | VWC | 2.39e-05 | 38 | 83 | 4 | SM00214 | |
| Domain | TIL_dom | 2.97e-05 | 14 | 83 | 3 | IPR002919 | |
| Domain | VWF_dom | 3.57e-05 | 42 | 83 | 4 | IPR001007 | |
| Domain | VWD | 4.55e-05 | 16 | 83 | 3 | SM00216 | |
| Domain | VWF_type-D | 4.55e-05 | 16 | 83 | 3 | IPR001846 | |
| Domain | VWFD | 4.55e-05 | 16 | 83 | 3 | PS51233 | |
| Domain | VWD | 4.55e-05 | 16 | 83 | 3 | PF00094 | |
| Domain | zf-C4 | 5.13e-05 | 46 | 83 | 4 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 5.13e-05 | 46 | 83 | 4 | IPR001628 | |
| Domain | NUCLEAR_REC_DBD_2 | 5.13e-05 | 46 | 83 | 4 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 5.13e-05 | 46 | 83 | 4 | PS00031 | |
| Domain | ZnF_C4 | 5.13e-05 | 46 | 83 | 4 | SM00399 | |
| Domain | - | 5.59e-05 | 47 | 83 | 4 | 1.10.565.10 | |
| Domain | - | 5.84e-05 | 3 | 83 | 2 | 1.20.1050.40 | |
| Domain | Pept_M3A_M3B | 5.84e-05 | 3 | 83 | 2 | IPR001567 | |
| Domain | Thiosulphate_STrfase_CS | 5.84e-05 | 3 | 83 | 2 | IPR001307 | |
| Domain | Peptidase_M3 | 5.84e-05 | 3 | 83 | 2 | PF01432 | |
| Domain | - | 5.84e-05 | 3 | 83 | 2 | 1.10.1370.10 | |
| Domain | Neurolysin/TOP_N | 5.84e-05 | 3 | 83 | 2 | IPR024080 | |
| Domain | Neurolysin/TOP_dom2 | 5.84e-05 | 3 | 83 | 2 | IPR024077 | |
| Domain | HOLI | 6.08e-05 | 48 | 83 | 4 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 6.08e-05 | 48 | 83 | 4 | IPR000536 | |
| Domain | Hormone_recep | 6.08e-05 | 48 | 83 | 4 | PF00104 | |
| Domain | CTCK_1 | 6.58e-05 | 18 | 83 | 3 | PS01185 | |
| Domain | EGF_Ca-bd_CS | 7.18e-05 | 97 | 83 | 5 | IPR018097 | |
| Domain | EGF_CA | 7.91e-05 | 99 | 83 | 5 | PS01187 | |
| Domain | CT | 1.23e-04 | 22 | 83 | 3 | SM00041 | |
| Domain | Cys_knot_C | 1.81e-04 | 25 | 83 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.81e-04 | 25 | 83 | 3 | PS01225 | |
| Domain | - | 1.93e-04 | 5 | 83 | 2 | 1.10.1450.10 | |
| Domain | CD81_LEL | 1.93e-04 | 5 | 83 | 2 | IPR028977 | |
| Domain | hEGF | 2.56e-04 | 28 | 83 | 3 | PF12661 | |
| Domain | WxxW_domain | 2.89e-04 | 6 | 83 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 2.89e-04 | 6 | 83 | 2 | PF13330 | |
| Domain | VWFC_1 | 5.44e-04 | 36 | 83 | 3 | PS01208 | |
| Domain | VWFC_2 | 6.38e-04 | 38 | 83 | 3 | PS50184 | |
| Domain | LAM_G_DOMAIN | 6.38e-04 | 38 | 83 | 3 | PS50025 | |
| Domain | Growth_fac_rcpt_ | 6.55e-04 | 156 | 83 | 5 | IPR009030 | |
| Domain | Laminin_G_2 | 7.43e-04 | 40 | 83 | 3 | PF02210 | |
| Domain | LamG | 9.83e-04 | 44 | 83 | 3 | SM00282 | |
| Domain | Fol_N | 1.05e-03 | 11 | 83 | 2 | IPR003645 | |
| Domain | FOLN | 1.05e-03 | 11 | 83 | 2 | SM00274 | |
| Domain | Nuclear_hrmn_rcpt | 1.12e-03 | 46 | 83 | 3 | IPR001723 | |
| Domain | ZnF_GATA | 1.25e-03 | 12 | 83 | 2 | SM00401 | |
| Domain | VitD_rcpt | 1.72e-03 | 14 | 83 | 2 | IPR000324 | |
| Domain | Ldl_recept_b | 1.72e-03 | 14 | 83 | 2 | PF00058 | |
| Domain | LDLRB | 1.72e-03 | 14 | 83 | 2 | PS51120 | |
| Domain | Znf_GATA | 1.97e-03 | 15 | 83 | 2 | IPR000679 | |
| Domain | GATA | 1.97e-03 | 15 | 83 | 2 | PF00320 | |
| Domain | LY | 1.97e-03 | 15 | 83 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.97e-03 | 15 | 83 | 2 | IPR000033 | |
| Domain | Laminin_G | 2.19e-03 | 58 | 83 | 3 | IPR001791 | |
| Domain | GATA_ZN_FINGER_1 | 2.25e-03 | 16 | 83 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 2.25e-03 | 16 | 83 | 2 | PS50114 | |
| Domain | Tetraspanin_CS | 3.88e-03 | 21 | 83 | 2 | IPR018503 | |
| Domain | RHOD | 4.25e-03 | 22 | 83 | 2 | SM00450 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 4.91e-06 | 28 | 58 | 4 | MM15042 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 6.53e-06 | 30 | 58 | 4 | M27323 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 1.72e-05 | 38 | 58 | 4 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 1.72e-05 | 38 | 58 | 4 | MM15865 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 4.39e-05 | 48 | 58 | 4 | MM14987 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 6.50e-05 | 53 | 58 | 4 | M8276 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE | 1.65e-04 | 5 | 58 | 2 | M29791 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE | 1.65e-04 | 5 | 58 | 2 | M29792 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 2.47e-04 | 6 | 58 | 2 | MM15663 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 5.65e-09 | 94 | 91 | 7 | 21542922 | |
| Pubmed | 2.14e-08 | 12 | 91 | 4 | 14557543 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.92e-08 | 4 | 91 | 3 | 10469592 | |
| Pubmed | 1.30e-07 | 18 | 91 | 4 | 18664271 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.73e-07 | 5 | 91 | 3 | 12629516 | |
| Pubmed | Nuclear receptors in Leydig cell gene expression and function. | 3.09e-07 | 22 | 91 | 4 | 20375256 | |
| Pubmed | CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. | 3.45e-07 | 6 | 91 | 3 | 9804823 | |
| Pubmed | 6.02e-07 | 7 | 91 | 3 | 18212046 | ||
| Pubmed | Phagocytosis imprints heterogeneity in tissue-resident macrophages. | 9.61e-07 | 8 | 91 | 3 | 28432199 | |
| Pubmed | Rhythmic modulation of the hematopoietic niche through neutrophil clearance. | 9.61e-07 | 8 | 91 | 3 | 23706740 | |
| Pubmed | 1.31e-06 | 31 | 91 | 4 | 19796621 | ||
| Pubmed | 2.71e-06 | 37 | 91 | 4 | 39178848 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FRAS1 FBN1 CELSR3 BTD PIEZO1 DHCR7 LRP1 LRP6 LANCL1 SLC39A14 ELAC2 NOTCH1 TMED4 DMXL1 | 2.85e-06 | 1201 | 91 | 14 | 35696571 |
| Pubmed | Genetic analysis of genes involved in amyloid-β degradation and clearance in Alzheimer's disease. | 3.75e-06 | 12 | 91 | 3 | 22027013 | |
| Pubmed | Sfrp1 and Sfrp2 are required for normal male sexual development in mice. | 4.86e-06 | 13 | 91 | 3 | 19100252 | |
| Pubmed | LXR deficiency confers increased protection against visceral Leishmania infection in mice. | 6.77e-06 | 2 | 91 | 2 | 21103366 | |
| Pubmed | Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose. | 6.77e-06 | 2 | 91 | 2 | 19933273 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 15539633 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 26324101 | ||
| Pubmed | Suppression of beta-catenin signaling by liver X receptor ligands. | 6.77e-06 | 2 | 91 | 2 | 18983830 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 23185273 | ||
| Pubmed | Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. | 6.77e-06 | 2 | 91 | 2 | 12483205 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19037100 | ||
| Pubmed | Liver X receptor-α/β expression ratio is increased in ACTH-secreting pituitary adenomas. | 6.77e-06 | 2 | 91 | 2 | 21356276 | |
| Pubmed | LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. | 6.77e-06 | 2 | 91 | 2 | 11149950 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 34799646 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 11851872 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 16325781 | ||
| Pubmed | Macrophages release plasma membrane-derived particles rich in accessible cholesterol. | 6.77e-06 | 2 | 91 | 2 | 30127022 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 26504234 | ||
| Pubmed | Myelin-derived lipids modulate macrophage activity by liver X receptor activation. | 6.77e-06 | 2 | 91 | 2 | 22984598 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 25980575 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19837721 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 17391100 | ||
| Pubmed | BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. | 6.77e-06 | 2 | 91 | 2 | 11792716 | |
| Pubmed | Accumulation of foam cells in liver X receptor-deficient mice. | 6.77e-06 | 2 | 91 | 2 | 12196343 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 17693624 | ||
| Pubmed | Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum. | 6.77e-06 | 2 | 91 | 2 | 26023184 | |
| Pubmed | Activation of the liver X receptor prevents lipopolysaccharide-induced lung injury. | 6.77e-06 | 2 | 91 | 2 | 19717840 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 33284790 | ||
| Pubmed | CD9 and CD81 Interactions and Their Structural Modelling in Sperm Prior to Fertilization. | 6.77e-06 | 2 | 91 | 2 | 29671763 | |
| Pubmed | Lxrα regulates the androgen response in prostate epithelium. | 6.77e-06 | 2 | 91 | 2 | 22547570 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 38250152 | ||
| Pubmed | Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses. | 6.77e-06 | 2 | 91 | 2 | 17766241 | |
| Pubmed | The medicinal chemistry of liver X receptor (LXR) modulators. | 6.77e-06 | 2 | 91 | 2 | 24832115 | |
| Pubmed | Improved metabolic control by depletion of Liver X Receptors in mice. | 6.77e-06 | 2 | 91 | 2 | 16876124 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 25796442 | ||
| Pubmed | Inhibition of SUV39H1 reduces tumor angiogenesis via Notch1 in oral squamous cell carcinoma. | 6.77e-06 | 2 | 91 | 2 | 38650654 | |
| Pubmed | Liver X receptors bridge hepatic lipid metabolism and inflammation. | 6.77e-06 | 2 | 91 | 2 | 22257474 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19380774 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 17405904 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 27335465 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19487338 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 17620116 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 17166844 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 15541382 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 23823481 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 21042792 | ||
| Pubmed | Phospholipase A(2)-modified low-density lipoprotein activates liver X receptor in human macrophages. | 6.77e-06 | 2 | 91 | 2 | 22367754 | |
| Pubmed | Liver X receptor (LXR) regulation of the LXRalpha gene in human macrophages. | 6.77e-06 | 2 | 91 | 2 | 11546778 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19122149 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 15548517 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 29572511 | ||
| Pubmed | Liver X receptors regulate adrenal steroidogenesis and hypothalamic-pituitary-adrenal feedback. | 6.77e-06 | 2 | 91 | 2 | 16973760 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 18840761 | ||
| Pubmed | Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. | 6.77e-06 | 2 | 91 | 2 | 17563384 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 34126068 | ||
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 6.77e-06 | 2 | 91 | 2 | 24484584 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19695240 | ||
| Pubmed | Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis. | 6.77e-06 | 2 | 91 | 2 | 23292650 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 12907682 | ||
| Pubmed | Differential regulation of gene expression by LXRs in response to macrophage cholesterol loading. | 6.77e-06 | 2 | 91 | 2 | 23686114 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 22073227 | ||
| Pubmed | Activation of Liver X Receptor Attenuates Oleic Acid-Induced Acute Respiratory Distress Syndrome. | 6.77e-06 | 2 | 91 | 2 | 27520356 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 15525595 | ||
| Pubmed | Laminar shear stress regulates liver X receptor in vascular endothelial cells. | 6.77e-06 | 2 | 91 | 2 | 18096827 | |
| Pubmed | Cholestenoic acid analogues as inverse agonists of the liver X receptors. | 6.77e-06 | 2 | 91 | 2 | 31931135 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 17587566 | ||
| Pubmed | Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. | 6.77e-06 | 2 | 91 | 2 | 12524534 | |
| Pubmed | Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice. | 6.77e-06 | 2 | 91 | 2 | 23675307 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19996385 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 29739800 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 18662991 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 16380109 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 27067807 | ||
| Pubmed | Swapping the substrate specificities of the neuropeptidases neurolysin and thimet oligopeptidase. | 6.77e-06 | 2 | 91 | 2 | 17251185 | |
| Pubmed | Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. | 6.77e-06 | 2 | 91 | 2 | 12368482 | |
| Pubmed | Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. | 6.77e-06 | 2 | 91 | 2 | 12040022 | |
| Pubmed | LXR-dependent gene expression is important for macrophage survival and the innate immune response. | 6.77e-06 | 2 | 91 | 2 | 15479645 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 34297734 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 34481107 | ||
| Pubmed | Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk. | 6.77e-06 | 2 | 91 | 2 | 26031789 | |
| Pubmed | The liver X receptor-{beta} is essential for maintaining cholesterol homeostasis in the testis. | 6.77e-06 | 2 | 91 | 2 | 15761042 | |
| Pubmed | LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration. | 6.77e-06 | 2 | 91 | 2 | 20364260 | |
| Pubmed | Levels of liver X receptors in testicular biopsies of patients with azoospermia. | 6.77e-06 | 2 | 91 | 2 | 24842676 | |
| Pubmed | CD81 interacts with the T cell receptor to suppress signaling. | 6.77e-06 | 2 | 91 | 2 | 23226274 | |
| Pubmed | Liver X receptor gene polymorphisms and adipose tissue expression levels in obesity. | 6.77e-06 | 2 | 91 | 2 | 17108812 | |
| Pubmed | Functional and genetic analysis in type 2 diabetes of liver X receptor alleles--a cohort study. | 6.77e-06 | 2 | 91 | 2 | 19292929 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 21134374 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 24100084 | ||
| Cytoband | 12q13.3 | 1.42e-04 | 51 | 90 | 3 | 12q13.3 | |
| GeneFamily | Nuclear hormone receptors | 1.36e-05 | 49 | 54 | 4 | 71 | |
| GeneFamily | Low density lipoprotein receptors | 6.69e-04 | 13 | 54 | 2 | 634 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 8.97e-04 | 15 | 54 | 2 | 82 | |
| GeneFamily | CD molecules|Mucins | 1.77e-03 | 21 | 54 | 2 | 648 | |
| GeneFamily | CD molecules|Tetraspanins | 4.36e-03 | 33 | 54 | 2 | 768 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.62e-03 | 34 | 54 | 2 | 487 | |
| GeneFamily | LIM domain containing | 1.34e-02 | 59 | 54 | 2 | 1218 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.30e-08 | 181 | 84 | 7 | 091e7975badd1ffa463a8ec87908be20781ecfd6 | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.50e-08 | 182 | 84 | 7 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.15e-08 | 185 | 84 | 7 | 46460e74cc613df9043f5404e7342aa13cc34873 | |
| ToppCell | P15-Mesenchymal|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.86e-08 | 188 | 84 | 7 | f1ba0b661621a65c91432e62ba73531bdf18e7c1 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-08 | 190 | 84 | 7 | 47077579496c5340e99f61499427a3a36b566da3 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-08 | 191 | 84 | 7 | a57cf0519d749febc0b69fe0b098b7ba53d63258 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-08 | 191 | 84 | 7 | 19c67a812b8ce97472d316acd15aeefe8736000d | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.21e-08 | 193 | 84 | 7 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.21e-08 | 193 | 84 | 7 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | P03-Mesenchymal|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.81e-08 | 195 | 84 | 7 | 6180309c6ae278b996fd98c57461cbc129c028ba | |
| ToppCell | E17.5-Mesenchymal|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.12e-08 | 196 | 84 | 7 | b4ee991445b612506372b9361ebfe72cb59b811e | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-08 | 196 | 84 | 7 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-08 | 196 | 84 | 7 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-07 | 200 | 84 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-07 | 200 | 84 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.63e-07 | 163 | 84 | 6 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.72e-07 | 174 | 84 | 6 | d77fa525d5c87c190b4a10787b270eabd16c610f | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-06 | 177 | 84 | 6 | 6f6cf93893daac6ae228df36219ee3acf8de8f97 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 178 | 84 | 6 | 5cc182e6faa7ba5b88378d2c953be29bbbb95a7e | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 178 | 84 | 6 | f9a16bc3f09c35c7d30e3809da024bc2dcf746ed | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-06 | 178 | 84 | 6 | ebfae386a518ea33911ba3ff40464c94d18ef695 | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-06 | 178 | 84 | 6 | ccd37575b60102f5e647c01546e8ff8fec638bd7 | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-06 | 178 | 84 | 6 | 87b04753650e45f12299c8456fb980d6c0d5961c | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-06 | 180 | 84 | 6 | 178648429686e6d4e6f3aafc350130e819788ecf | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-06 | 180 | 84 | 6 | fcd5d5bf00ee728162b0aac4c81eb78e742cf6f2 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-06 | 180 | 84 | 6 | c2a8f61c806f6f6f47743e9f7c9700705db43386 | |
| ToppCell | facs-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-06 | 181 | 84 | 6 | 72c28baf4fd417ff4a7068603830d55074960144 | |
| ToppCell | facs-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-06 | 181 | 84 | 6 | 2ac4d3e8987d5a009d7908d8787e18165826202a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-06 | 181 | 84 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Lung-3m-Endothelial-venous_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-06 | 181 | 84 | 6 | 2628c7ac345eaaeecf8e34617e81948925962cb9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-06 | 181 | 84 | 6 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.43e-06 | 186 | 84 | 6 | 88e6246172d816806a498a5c1f38e699f2f5d7c2 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.48e-06 | 187 | 84 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 189 | 84 | 6 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 190 | 84 | 6 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 190 | 84 | 6 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 190 | 84 | 6 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 190 | 84 | 6 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 190 | 84 | 6 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-06 | 191 | 84 | 6 | 9431ffd6b758f756609d9057de2023596e22b5d4 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-06 | 191 | 84 | 6 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | facs-Lung-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-06 | 191 | 84 | 6 | ba02cbdfda6a94374a6472eb88499059979af472 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-06 | 191 | 84 | 6 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 192 | 84 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 192 | 84 | 6 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.72e-06 | 192 | 84 | 6 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 192 | 84 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 193 | 84 | 6 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 193 | 84 | 6 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-06 | 193 | 84 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.77e-06 | 193 | 84 | 6 | 5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.77e-06 | 193 | 84 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 193 | 84 | 6 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 193 | 84 | 6 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.83e-06 | 194 | 84 | 6 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-06 | 194 | 84 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.83e-06 | 194 | 84 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-06 | 194 | 84 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-06 | 195 | 84 | 6 | 6bb6349d6ec8da094fe1c7c590021989337aeb0b | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.88e-06 | 195 | 84 | 6 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-06 | 195 | 84 | 6 | 223f5f07dc28fa13a09bb589884c58043c7928c7 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-06 | 195 | 84 | 6 | a3b468125e48f072255cede7645f6692298ecf54 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.94e-06 | 196 | 84 | 6 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.94e-06 | 196 | 84 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PND07-Mesenchymal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-06 | 196 | 84 | 6 | 0050c7134473fbfd7b9f0ae8d6d337713e60b57d | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-06 | 197 | 84 | 6 | 06a0d7062dadda656decaf77dcef9a10b5f2698d | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-06 | 197 | 84 | 6 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | PND01-Mesenchymal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-06 | 197 | 84 | 6 | 292b8cc3dafddf5d323fe4e3d3ea5ac61e6ce027 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.00e-06 | 197 | 84 | 6 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-06 | 197 | 84 | 6 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 197 | 84 | 6 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-06 | 197 | 84 | 6 | d35c7a36135b5ed6a7bf2f934849678eba2a0177 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 2.00e-06 | 197 | 84 | 6 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-06 | 198 | 84 | 6 | 8f202ed4692ea2c139ff05d4805c704ee4be095c | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.06e-06 | 198 | 84 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-06 | 198 | 84 | 6 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.06e-06 | 198 | 84 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-06 | 198 | 84 | 6 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 2.12e-06 | 199 | 84 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-06 | 199 | 84 | 6 | 5059a1d4df7d9989c922007a8dcba98b1f5687d5 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.12e-06 | 199 | 84 | 6 | f19c683f38bca3bfee40396f27423441051dec67 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.12e-06 | 199 | 84 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-06 | 199 | 84 | 6 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-06 | 200 | 84 | 6 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.18e-06 | 200 | 84 | 6 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.18e-06 | 200 | 84 | 6 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-06 | 200 | 84 | 6 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.18e-06 | 200 | 84 | 6 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.18e-06 | 200 | 84 | 6 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-intermediate_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.18e-06 | 200 | 84 | 6 | 6461d25fd8fb52921b188f083fbe808535d3130b | |
| Computational | Metal / Ca ion binding. | 5.09e-05 | 133 | 54 | 6 | MODULE_324 | |
| Disease | aortic aneurysm | 3.55e-04 | 10 | 84 | 2 | EFO_0001666 | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 3.55e-04 | 10 | 84 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | 46,XY partial gonadal dysgenesis | 4.33e-04 | 11 | 84 | 2 | C4510744 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 5.19e-04 | 12 | 84 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | Liver carcinoma | 6.15e-04 | 507 | 84 | 7 | C2239176 | |
| Disease | cholangiocarcinoma (is_marker_for) | 8.18e-04 | 64 | 84 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Autistic Disorder | 9.11e-04 | 261 | 84 | 5 | C0004352 | |
| Disease | Alcohol abuse | 9.35e-04 | 67 | 84 | 3 | C0085762 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 1.06e-03 | 17 | 84 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | behavior or behavioral disorder measurement, personality trait | 1.19e-03 | 18 | 84 | 2 | EFO_0004365, EFO_0004782 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 1.47e-03 | 20 | 84 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | Glioblastoma | 1.51e-03 | 79 | 84 | 3 | C0017636 | |
| Disease | disease of metabolism (implicated_via_orthology) | 1.62e-03 | 21 | 84 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Giant Cell Glioblastoma | 1.80e-03 | 84 | 84 | 3 | C0334588 | |
| Disease | congenital heart disease (is_implicated_in) | 2.12e-03 | 24 | 84 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | obesity (is_implicated_in) | 2.26e-03 | 91 | 84 | 3 | DOID:9970 (is_implicated_in) | |
| Disease | Cerebral Astrocytoma | 2.30e-03 | 25 | 84 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 2.30e-03 | 25 | 84 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 2.30e-03 | 25 | 84 | 2 | C0334583 | |
| Disease | Astrocytoma | 2.30e-03 | 25 | 84 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 2.30e-03 | 25 | 84 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 2.30e-03 | 25 | 84 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 2.30e-03 | 25 | 84 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 2.30e-03 | 25 | 84 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 2.30e-03 | 25 | 84 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 2.30e-03 | 25 | 84 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 2.49e-03 | 26 | 84 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 2.49e-03 | 26 | 84 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 2.49e-03 | 26 | 84 | 2 | C0334582 | |
| Disease | Anaplastic astrocytoma | 2.68e-03 | 27 | 84 | 2 | C0334579 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CGTGIISLFCAHYAR | 146 | P55345 | |
| GCSGYCLSHQLLFFL | 191 | Q6UX73 | |
| CLLGCGFSTGYGAAI | 176 | P08319 | |
| GATVFGSLDCYHGLC | 121 | Q5VUY2 | |
| NAFGNTALHIACYLG | 236 | Q8NB46 | |
| LAYCLACGGGHLLPY | 416 | Q9UBM7 | |
| FLPNDCLLYGGDCSH | 271 | Q9Y485 | |
| GFLGCYGAIQESQCL | 76 | P60033 | |
| GGRTCSGLAYDFQLC | 596 | O95450 | |
| CLGTCVAYGDGHFIT | 891 | Q9HC84 | |
| SGFHYNVLSCEGCKG | 106 | Q13133 | |
| HCQHGGICLNLPGSY | 191 | P0DPK3 | |
| NGLLCHILDYSFGGG | 1421 | P46531 | |
| VHSCGLGFYQAGSLC | 451 | Q86XX4 | |
| LCHGSAGNAYAFLTL | 321 | O43813 | |
| LYAGVALFCGCGHEA | 36 | P51674 | |
| GGHKCACPTNFYLGS | 3311 | Q07954 | |
| FRNHTCGLCGDYNGL | 161 | Q02817 | |
| HCGYLALVTSLSCGA | 211 | P08237 | |
| YHARCLPHLGGGTCL | 521 | P14222 | |
| CGFLGIYHLGAASAL | 11 | P41247 | |
| GCGLSLATSGRCYHL | 531 | Q6UWB1 | |
| KLNLCLYCGTGGHYA | 291 | Q86TG7 | |
| FCTGSGLGCHYLHLD | 456 | A0A1B0GTW7 | |
| NGGCSHLCLYRPQGL | 596 | O75581 | |
| AGAGDLCALCGEHLY | 691 | Q8TDZ2 | |
| QGQGGLHGIYLRAFC | 76 | Q9UGJ1 | |
| LICGDEASGCHYGAL | 561 | P10275 | |
| GLAGCRLCHYVCGVS | 86 | Q15722 | |
| GCATQHFLYLCLGGA | 96 | Q8NHA4 | |
| CGYCGRAFAGATTLN | 531 | Q9NQX0 | |
| CGSHLCVVSLFYGTG | 241 | Q8NG98 | |
| RDGTGHYLCNACGLY | 276 | P23771 | |
| TFGGKCYNCGQIGHL | 541 | P87889 | |
| TFGGKCYNCGQIGHL | 541 | Q9YNA8 | |
| DGTGHYLCNACGLYH | 231 | P43694 | |
| TFGGKCYNCGQIGHL | 541 | P62683 | |
| TFGGKCYNCGQIGHL | 541 | P63145 | |
| TFGGKCYNCGQIGHL | 541 | P63130 | |
| TFGGKCYNCGQIGHL | 541 | P62685 | |
| TFGGKCYNCGQIGHL | 541 | P63126 | |
| TFGGKCYNCGQIGHL | 541 | P62684 | |
| IHYALNCCGLAGGVE | 146 | P21926 | |
| GGNKCGACGRTVYHA | 6 | Q16527 | |
| TGCGRCLANGGIHYI | 4851 | Q9Y6R7 | |
| GNALVCTCYGGSRGF | 71 | P02751 | |
| ICGGASCHNTLGSYK | 2616 | P35555 | |
| FLCGCYVVALGAHTG | 31 | P43251 | |
| CLAGALLGDCVGSFY | 26 | Q9NX46 | |
| ATYGCGHCGALYAAL | 356 | Q96SL8 | |
| LAAAVCGGVCHGLYL | 141 | Q9BSK0 | |
| CGGVCHGLYLLSALY | 146 | Q9BSK0 | |
| HCASALGLGCYVAAA | 246 | Q12894 | |
| YGSICSFHCLEGQLL | 726 | P16109 | |
| EAHGGYTFCGLAALV | 246 | P49356 | |
| ALDGHLYAIGGECLN | 586 | Q5VTJ3 | |
| GCGLCTMHNYLFLAG | 346 | Q96G42 | |
| AFHYLHAGLCGLQGL | 2751 | Q9NYQ7 | |
| CLHGGLCVDGENRYS | 271 | P82279 | |
| CGFTSAGHVLCGYPL | 66 | P51172 | |
| AGHVLCGYPLCLLSG | 71 | P51172 | |
| GHFVLSCSYDGLDCQ | 421 | P51172 | |
| ACCCYLGLAFGILAG | 406 | Q15043 | |
| CYHPIFCGNLSGGDL | 936 | Q2WGJ9 | |
| HCCLGSARGLFLFGQ | 16 | Q96HF1 | |
| SGYHYGLLTCESCKG | 21 | Q13285 | |
| GVTACHVALGAYLCG | 251 | P25325 | |
| GLLFVCLHCALSYQG | 151 | Q86TG1 | |
| CGSHLSIVLLFYGAG | 241 | Q8NG99 | |
| GFHYNVLSCEGCKGF | 96 | P55055 | |
| TCGKNLADCLGHYGY | 71 | O14802 | |
| TGGCCPGASLHKFAY | 191 | O43463 | |
| TFGGKCYNCGQIGHL | 541 | P63128 | |
| YNHAACFGLQPGCLL | 446 | Q9BYT8 | |
| LYLLFSVNGSGHFCG | 461 | Q7Z739 | |
| GCGLCGQSFAGAYDL | 821 | P0CJ78 | |
| DCGKACGGFYLLNEH | 341 | Q96MU6 | |
| CGEGTFGQLCRHYGD | 516 | Q9BQ52 | |
| HIFLAGCTGGFLQAY | 101 | Q8N413 | |
| YHSALGGGDALCCEL | 221 | Q9BYB0 | |
| GFLIGAGIAAYLACH | 266 | Q6T4P5 | |
| AGIAAYLACHAVGNF | 271 | Q6T4P5 | |
| CNTPGGFLLHYCLLA | 101 | Q6ZQN7 | |
| FSYSCKCLEGHGGVL | 1391 | O94813 | |
| HSSQRYCGVCLGLLA | 181 | A0PJX8 | |
| YCGVCLGLLAHAHGL | 186 | A0PJX8 | |
| GALYCLLGNHSGVCL | 1026 | Q14997 | |
| VLLGNICYNCGRSGH | 61 | Q8WW36 | |
| ALSQHCYAGSGCPLL | 11 | Q13296 | |
| GCSFLNCYITFDAGH | 126 | Q9H7R0 | |
| ALCATGAQGLYFHIG | 21 | Q7Z7H5 | |
| AVGCFGAGHLICLYC | 251 | Q92508 | |
| GGLEFGAECYCGHKI | 171 | Q2TBF2 | |
| GVTACHVALAAYLCG | 251 | Q16762 | |
| LIHLGCYFSSGSCGK | 11 | Q9BY64 | |
| KYGHAACFGLQPGCL | 421 | P52888 | |
| GGCDLQLNVCLFYVG | 636 | A6NCI4 | |
| YLNGGTCACFEILGF | 361 | A6NNM8 | |
| FHYCIGNGFSRELTC | 76 | Q86UP9 |